Medtech giant Medtronic has successfully seen two patents for its sacral neuromodulation (SNM) upheld before US courts, ...

The Medtronic company offices in Fridley, Minn. (Jim Mone/AP) Medtronic said Friday that the U.S. Food and Drug Administration has approved a new spinal-cord implant that relieves chronic pain ...

ARECOR AND MEDTRONIC DIABETES ESTABLISH COLLABORATION TO DEVELOP A NOVEL THERMOSTABLE INSULIN FOR IMPLANTABLE PUMP DELIVERY Medtronic to fund Arecor’s development of Arestat™ enabled novel ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Medtronic plc MDT recently presented a set of new clinical and real-world evidence on the MiniMed 780G system from around the world. The latest data reveals that the system withstands strong global ...

Investors in Medtronic PLC (Symbol: MDT) saw new options become available today, for the June 7th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MDT ...

A special interest's lobbying activity may go up or down over time, depending on how much attention the federal government is giving their issues. Particularly active clients often retain multiple ...

Medtronic has secured FDA approval for its first closed-loop spinal cord stimulator, designed to take in signals from the body and adjust its therapy automatically. The Inceptiv implant for ...

Medtronic plc MDT is likely to grow in the coming quarters, backed by remarkable progress within the Cardiovascular portfolio. The Cranial and Spinal technologies business within the company’s ...

The projected fair value for Medtronic is US$100 based on 2 Stage Free Cash Flow to Equity With US$80.38 share price, Medtronic appears to be trading close to its estimated fair value Analyst ...